Difficulty: Medium
Average Score: 91%
Practice
Malignant mutation in hypertrophic cardiomyopathy is which of the following?
Correct answer
A
Rationale
In the context of pediatric nursing and cardiovascular disorders, understanding the genetic mutations associated with hypertrophic cardiomyopathy is crucial for providing effective care. The correct answer is A) Arg 403 Gln. This mutation involves a substitution of amino acids in the gene encoding for beta-myosin heavy chain. This specific mutation is commonly found in cases of hypertrophic cardiomyopathy and is associated with a more malignant course of the disease.
Option B) Gln 403 Arg is incorrect because the order of the amino acids is reversed, leading to a different mutation with potentially different implications for disease progression. Option C) Arg 304 Gln and Option D) Gln 304 Arg are also incorrect as they refer to different amino acid positions which are not typically associated with hypertrophic cardiomyopathy.
Educationally, understanding the specific genetic mutations involved in hypertrophic cardiomyopathy not only aids in accurate diagnosis but also in tailoring treatment plans and prognostic evaluations for pediatric patients. By knowing the significance of the Arg 403 Gln mutation, nurses and healthcare providers can offer more targeted and personalized care to children with this condition.
Option B) Gln 403 Arg is incorrect because the order of the amino acids is reversed, leading to a different mutation with potentially different implications for disease progression. Option C) Arg 304 Gln and Option D) Gln 304 Arg are also incorrect as they refer to different amino acid positions which are not typically associated with hypertrophic cardiomyopathy.
Educationally, understanding the specific genetic mutations involved in hypertrophic cardiomyopathy not only aids in accurate diagnosis but also in tailoring treatment plans and prognostic evaluations for pediatric patients. By knowing the significance of the Arg 403 Gln mutation, nurses and healthcare providers can offer more targeted and personalized care to children with this condition.